Ametek (AME) Tops Q1 EPS by 6c; offers guidance
Tweet
Share
E-mail
Get Alerts AME Hot Sheet
Price: $239.08 +0.57%
Revenue Growth %: +9.5%
Financial Fact:
Basic shares: 231.89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +9.5%
Financial Fact:
Basic shares: 231.89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Ametek (NYSE: AME) reported Q1 EPS of $1.75, $0.06 better than the analyst estimate of $1.69. Revenue for the quarter came in at $1.73 billion versus the consensus estimate of $1.74 billion.
GUIDANCE:
Ametek sees FY2025 EPS of $7.02-$7.18, versus the consensus of $7.08.
For earnings history and earnings-related data on Ametek (AME) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Royalty Pharma (RPRX) PT Raised to $68 at TD Cowen
- Roivant Sciences (ROIV) PT Raised to $55 at Piper Sandler
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
